AMGN vs ATHA
Amgen Inc (AMGN) versus Athira Pharma Inc (ATHA) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Athira Pharma Inc (ATHA) is a biotechnology company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
ATHA does not have a complete income-statement cache yet.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. ATHA currently screens at market cap $26.6M.
Not investment advice. Open the AMGN and ATHA stock pages for the full models.
Not investment advice.